| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
91,292 |
80,837 |
$46.57M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
128,457 |
117,346 |
$41.98M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
100,818 |
94,772 |
$28.47M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
20,889 |
19,448 |
$16.40M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12,923 |
11,939 |
$6.77M |
| 44970 |
|
1,405 |
1,337 |
$6.28M |
| 70450 |
Computed tomography, head or brain; without contrast material |
35,245 |
32,158 |
$5.02M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
3,232 |
2,998 |
$4.38M |
| 47562 |
|
945 |
882 |
$3.91M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29,950 |
28,685 |
$3.75M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12,468 |
11,467 |
$2.56M |
| G0378 |
Hospital observation service, per hour |
66,640 |
31,846 |
$2.29M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,174 |
2,038 |
$2.23M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,321 |
2,196 |
$1.60M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,593 |
4,211 |
$1.27M |
| 70496 |
|
2,290 |
2,124 |
$1.26M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,692 |
1,651 |
$1.25M |
| 74174 |
|
1,355 |
1,225 |
$1.22M |
| L8699 |
Prosthetic implant, not otherwise specified |
1,017 |
954 |
$1.04M |
| 92552 |
|
3,275 |
3,203 |
$932K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
10,853 |
7,078 |
$893K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
8,865 |
8,157 |
$834K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
355 |
350 |
$830K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,571 |
2,468 |
$817K |
| 72131 |
|
2,170 |
2,012 |
$798K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
290 |
218 |
$789K |
| 95811 |
|
1,141 |
1,079 |
$730K |
| 80053 |
Comprehensive metabolic panel |
177,543 |
142,386 |
$714K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,712 |
4,852 |
$700K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,511 |
2,166 |
$552K |
| 70491 |
|
1,334 |
1,270 |
$549K |
| 93458 |
|
329 |
296 |
$499K |
| 70486 |
|
5,244 |
4,951 |
$493K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
4,070 |
3,785 |
$428K |
| 93970 |
|
1,784 |
1,657 |
$422K |
| 36430 |
|
1,894 |
1,487 |
$395K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,661 |
6,089 |
$388K |
| C1776 |
Joint device (implantable) |
368 |
341 |
$385K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26,885 |
21,764 |
$362K |
| 95782 |
|
397 |
389 |
$312K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
44,387 |
36,456 |
$302K |
| 49083 |
|
697 |
383 |
$299K |
| 54161 |
|
206 |
201 |
$291K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,100 |
2,044 |
$275K |
| 92582 |
|
763 |
742 |
$257K |
| 95812 |
|
1,487 |
1,456 |
$242K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
133 |
115 |
$231K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,145 |
1,101 |
$227K |
| 52356 |
|
61 |
50 |
$216K |
| 71250 |
|
2,058 |
1,896 |
$215K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,512 |
1,586 |
$215K |
| 93798 |
|
2,867 |
455 |
$213K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,342 |
1,280 |
$211K |
| 93971 |
|
4,608 |
4,112 |
$210K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,921 |
1,592 |
$193K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
180 |
177 |
$193K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,330 |
10,828 |
$190K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,428 |
1,181 |
$184K |
| 76770 |
|
3,028 |
2,910 |
$160K |
| 92611 |
|
1,035 |
995 |
$145K |
| 10060 |
|
1,503 |
1,424 |
$145K |
| 72146 |
|
750 |
679 |
$122K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
495 |
481 |
$111K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
76,439 |
58,702 |
$105K |
| 74230 |
|
1,055 |
1,016 |
$103K |
| C1769 |
Guide wire |
4,596 |
4,112 |
$102K |
| 20680 |
|
85 |
76 |
$101K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,915 |
3,631 |
$100K |
| 80320 |
|
28,450 |
25,388 |
$89K |
| G0390 |
Trauma response team associated with hospital critical care service |
100 |
90 |
$88K |
| 92523 |
|
348 |
332 |
$87K |
| 74455 |
|
340 |
323 |
$85K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
24,803 |
21,029 |
$84K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13,300 |
12,086 |
$77K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
37,409 |
26,050 |
$77K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
9,156 |
6,276 |
$75K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
21,594 |
16,847 |
$73K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
415 |
406 |
$72K |
| 93976 |
|
9,404 |
8,713 |
$70K |
| 70498 |
|
2,640 |
2,464 |
$69K |
| 92557 |
|
227 |
224 |
$66K |
| 92587 |
|
4,967 |
4,852 |
$63K |
| 95819 |
|
477 |
450 |
$61K |
| 92526 |
|
969 |
470 |
$59K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
1,726 |
981 |
$57K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,115 |
1,078 |
$57K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
92 |
90 |
$56K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
71,688 |
56,868 |
$54K |
| 88341 |
|
825 |
516 |
$54K |
| 70487 |
|
124 |
120 |
$53K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21,511 |
13,601 |
$52K |
| 86920 |
|
1,944 |
1,076 |
$51K |
| 70544 |
|
1,132 |
1,010 |
$51K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
732 |
658 |
$50K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
88,385 |
77,651 |
$47K |
| 29827 |
|
47 |
37 |
$44K |
| 71046 |
Radiologic examination, chest; 2 views |
25,738 |
24,232 |
$42K |
| 96409 |
|
558 |
397 |
$42K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
656 |
640 |
$41K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
5,745 |
4,675 |
$41K |
| 36821 |
|
31 |
30 |
$39K |
| 82728 |
|
2,915 |
2,697 |
$35K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,742 |
8,510 |
$35K |
| 0225U |
|
515 |
504 |
$34K |
| 96376 |
|
31,359 |
18,690 |
$32K |
| 36561 |
|
13 |
13 |
$31K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,945 |
1,360 |
$29K |
| 72141 |
|
1,423 |
1,255 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
184,779 |
148,656 |
$27K |
| 95800 |
|
235 |
234 |
$27K |
| 12011 |
|
2,724 |
2,608 |
$27K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
59 |
51 |
$26K |
| 72128 |
|
1,070 |
982 |
$25K |
| 92585 |
|
110 |
100 |
$24K |
| 74240 |
|
125 |
124 |
$24K |
| 58662 |
|
15 |
12 |
$24K |
| 51600 |
|
347 |
331 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,608 |
19,986 |
$23K |
| 92556 |
|
237 |
236 |
$21K |
| 92610 |
|
250 |
237 |
$20K |
| 99215 |
Prolong outpt/office vis |
53 |
49 |
$18K |
| J1756 |
Injection, iron sucrose, 1 mg |
367 |
188 |
$18K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,286 |
2,138 |
$18K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
22 |
14 |
$18K |
| 90378 |
|
175 |
149 |
$17K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,682 |
1,374 |
$17K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,800 |
5,482 |
$16K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
262 |
242 |
$16K |
| 86923 |
|
1,748 |
1,028 |
$16K |
| 87631 |
|
15,106 |
14,754 |
$15K |
| 95816 |
|
199 |
181 |
$15K |
| 10061 |
|
40 |
38 |
$14K |
| 64642 |
|
88 |
86 |
$14K |
| 12001 |
|
2,812 |
2,716 |
$12K |
| 76801 |
|
5,288 |
4,724 |
$11K |
| 76885 |
|
224 |
213 |
$10K |
| 0450 |
Emergency room services |
236 |
220 |
$10K |
| Q9964 |
High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
348 |
320 |
$10K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
4,017 |
2,461 |
$9K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
427 |
403 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
47,671 |
42,516 |
$9K |
| 97116 |
|
5,594 |
3,986 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13,455 |
11,362 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
285 |
80 |
$8K |
| 96367 |
|
4,057 |
2,906 |
$8K |
| 29826 |
|
45 |
39 |
$8K |
| 74018 |
|
5,029 |
4,703 |
$7K |
| 92567 |
|
6,118 |
5,946 |
$7K |
| 76830 |
Ultrasound, transvaginal |
3,420 |
3,249 |
$7K |
| 72158 |
|
28 |
25 |
$7K |
| 73700 |
|
39 |
38 |
$7K |
| 74181 |
|
17 |
13 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,713 |
2,420 |
$7K |
| 84702 |
|
15,445 |
14,124 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
47,174 |
43,862 |
$6K |
| 88307 |
|
2,173 |
1,748 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,150 |
10,068 |
$6K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
337 |
91 |
$6K |
| 97802 |
|
202 |
170 |
$6K |
| 86850 |
|
14,037 |
12,586 |
$5K |
| 76536 |
|
130 |
125 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49,089 |
42,204 |
$5K |
| 72100 |
|
2,571 |
2,398 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
37,826 |
34,781 |
$5K |
| 36591 |
|
1,294 |
820 |
$5K |
| J3490 |
Unclassified drugs |
143,793 |
65,839 |
$5K |
| 82803 |
|
5,256 |
4,350 |
$5K |
| 12002 |
|
1,774 |
1,694 |
$5K |
| 97161 |
|
4,785 |
4,225 |
$5K |
| 95806 |
|
40 |
40 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,413 |
1,279 |
$4K |
| 73562 |
|
7,000 |
6,048 |
$4K |
| 73130 |
|
4,897 |
4,417 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,869 |
7,509 |
$4K |
| 97165 |
|
2,601 |
2,299 |
$4K |
| 92553 |
|
13 |
12 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,702 |
16,321 |
$4K |
| 73630 |
|
5,158 |
4,725 |
$4K |
| 59025 |
Fetal non-stress test |
786 |
658 |
$4K |
| 88342 |
|
1,924 |
1,627 |
$4K |
| 73090 |
|
3,780 |
3,164 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
84,382 |
68,690 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
45,989 |
33,667 |
$3K |
| 73610 |
|
4,919 |
4,488 |
$3K |
| 76800 |
|
30 |
30 |
$3K |
| 82784 |
|
1,110 |
716 |
$3K |
| 81025 |
|
32,125 |
29,746 |
$3K |
| 83690 |
|
60,006 |
53,289 |
$3K |
| 87040 |
|
21,477 |
13,154 |
$3K |
| 84484 |
|
47,183 |
28,748 |
$3K |
| 74021 |
|
11,276 |
10,588 |
$3K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
137,467 |
56,419 |
$3K |
| 81001 |
|
82,905 |
75,188 |
$3K |
| 76870 |
|
1,883 |
1,764 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
8,009 |
7,568 |
$2K |
| 97162 |
|
1,178 |
1,072 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,688 |
2,421 |
$2K |
| 82947 |
|
67,218 |
38,463 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,011 |
7,574 |
$2K |
| 70360 |
|
143 |
128 |
$2K |
| 75574 |
|
27 |
27 |
$2K |
| 92652 |
|
12 |
12 |
$2K |
| 73030 |
|
5,183 |
4,553 |
$2K |
| 81003 |
|
36,561 |
33,713 |
$2K |
| 72040 |
|
828 |
705 |
$2K |
| 77076 |
|
431 |
417 |
$2K |
| 97803 |
|
90 |
89 |
$2K |
| 73590 |
|
3,444 |
2,980 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
38,552 |
35,564 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
6,675 |
4,470 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,037 |
3,681 |
$2K |
| 87430 |
|
18,456 |
17,640 |
$2K |
| 83880 |
|
10,344 |
9,266 |
$2K |
| 80329 |
|
2,532 |
2,270 |
$2K |
| G0379 |
Direct admission of patient for hospital observation care |
1,567 |
1,492 |
$1K |
| 73552 |
|
1,715 |
1,495 |
$1K |
| 82550 |
|
16,569 |
14,008 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
28,320 |
26,053 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
48,584 |
40,622 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
442 |
430 |
$1K |
| 73080 |
|
2,585 |
2,380 |
$1K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
20,142 |
18,177 |
$1K |
| 84703 |
|
21,313 |
19,971 |
$1K |
| 73502 |
|
2,623 |
2,286 |
$1K |
| 76882 |
|
46 |
41 |
$1K |
| 83605 |
|
19,058 |
15,108 |
$1K |
| 90715 |
|
6,060 |
5,767 |
$1K |
| 72156 |
|
13 |
12 |
$1K |
| 83735 |
|
23,851 |
17,884 |
$1K |
| 70547 |
|
676 |
609 |
$1K |
| 87186 |
|
11,056 |
9,903 |
$989.05 |
| 80061 |
Lipid panel |
3,376 |
2,941 |
$975.02 |
| 85610 |
|
40,133 |
34,701 |
$942.78 |
| 85027 |
|
19,819 |
14,780 |
$929.96 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
38 |
36 |
$929.01 |
| 87088 |
|
29,668 |
26,344 |
$921.35 |
| 85730 |
|
20,068 |
18,086 |
$920.65 |
| 73140 |
|
1,857 |
1,744 |
$910.27 |
| 73110 |
|
2,774 |
2,485 |
$856.65 |
| 87081 |
|
10,546 |
10,129 |
$843.16 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
3,955 |
2,884 |
$836.13 |
| 82657 |
|
282 |
270 |
$793.33 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
10,367 |
8,582 |
$648.42 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
30,641 |
27,392 |
$647.17 |
| 83021 |
|
138 |
135 |
$645.07 |
| J2060 |
Injection, lorazepam, 2 mg |
8,688 |
7,291 |
$630.03 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,499 |
3,812 |
$604.60 |
| 86901 |
|
17,102 |
15,532 |
$550.88 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
327 |
289 |
$540.17 |
| 85379 |
|
5,573 |
5,171 |
$535.82 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
7,015 |
6,321 |
$534.27 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
24 |
20 |
$524.95 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,248 |
4,180 |
$517.37 |
| 76010 |
|
600 |
571 |
$515.43 |
| 87070 |
|
4,023 |
3,284 |
$512.01 |
| J9370 |
Vincristine sulfate, 1 mg |
633 |
436 |
$477.35 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
819 |
707 |
$468.18 |
| 74420 |
|
369 |
341 |
$465.38 |
| 87075 |
|
2,578 |
2,036 |
$451.79 |
| 72170 |
|
2,457 |
2,225 |
$450.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,173 |
5,868 |
$445.98 |
| 85055 |
|
4,480 |
2,833 |
$444.39 |
| 86900 |
|
15,578 |
14,152 |
$430.35 |
| 94760 |
|
8,112 |
3,848 |
$392.76 |
| 87077 |
|
14,010 |
11,931 |
$366.73 |
| 73600 |
|
239 |
203 |
$355.00 |
| 84145 |
|
5,161 |
4,773 |
$345.04 |
| 94644 |
|
979 |
933 |
$343.01 |
| 29505 |
|
113 |
105 |
$318.00 |
| 84550 |
|
2,369 |
2,039 |
$307.48 |
| 82565 |
|
5,676 |
5,018 |
$304.30 |
| 86140 |
|
14,315 |
12,893 |
$301.07 |
| 82607 |
|
1,881 |
1,660 |
$300.76 |
| 29125 |
|
825 |
766 |
$299.04 |
| 97166 |
|
758 |
698 |
$280.48 |
| 87210 |
|
5,082 |
4,831 |
$277.70 |
| 84100 |
|
8,579 |
5,875 |
$269.29 |
| A9270 |
Non-covered item or service |
126,322 |
14,620 |
$267.90 |
| 93880 |
|
13 |
12 |
$266.54 |
| 92555 |
|
4,048 |
3,968 |
$259.31 |
| 73060 |
|
1,151 |
965 |
$257.79 |
| 80051 |
|
1,561 |
1,392 |
$237.60 |
| 84450 |
|
1,328 |
1,110 |
$220.00 |
| 72192 |
|
16 |
12 |
$207.89 |
| J1953 |
Injection, levetiracetam, 10 mg |
2,151 |
1,689 |
$205.72 |
| 84520 |
|
5,131 |
4,553 |
$203.43 |
| 84460 |
|
1,564 |
1,325 |
$203.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
12,793 |
6,351 |
$197.18 |
| 80164 |
|
627 |
501 |
$181.65 |
| 73120 |
|
158 |
143 |
$179.08 |
| J1644 |
Injection, heparin sodium, per 1000 units |
8,717 |
4,167 |
$178.02 |
| 88304 |
|
3,885 |
3,596 |
$175.11 |
| 82533 |
|
25 |
17 |
$171.39 |
| 86592 |
|
1,149 |
1,055 |
$167.22 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16,711 |
13,037 |
$167.05 |
| 94762 |
|
15 |
13 |
$163.12 |
| 84132 |
|
6,581 |
5,365 |
$156.04 |
| 86635 |
|
849 |
434 |
$153.18 |
| 70250 |
|
32 |
29 |
$152.90 |
| 96368 |
|
818 |
618 |
$151.68 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,192 |
592 |
$151.10 |
| J1956 |
Injection, levofloxacin, 250 mg |
2,055 |
1,466 |
$151.02 |
| 72072 |
|
162 |
151 |
$149.04 |
| 85384 |
|
1,306 |
1,207 |
$148.50 |
| 73560 |
|
989 |
849 |
$130.71 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,573 |
1,519 |
$129.32 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
4,897 |
2,748 |
$126.32 |
| 84466 |
|
2,298 |
2,147 |
$122.22 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
3,749 |
2,242 |
$121.75 |
| 84156 |
|
2,143 |
1,787 |
$117.81 |
| 94761 |
|
33 |
25 |
$115.65 |
| J3535 |
Drug administered through a metered dose inhaler |
2,002 |
1,899 |
$114.23 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,506 |
2,983 |
$114.04 |
| 71101 |
|
86 |
77 |
$113.03 |
| 85018 |
|
7,306 |
5,970 |
$112.50 |
| 73000 |
|
529 |
491 |
$110.21 |
| 86780 |
|
176 |
166 |
$103.00 |
| 84112 |
|
413 |
381 |
$99.55 |
| 82140 |
|
2,350 |
2,015 |
$98.44 |
| 84439 |
|
2,887 |
2,593 |
$95.13 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,448 |
5,647 |
$92.46 |
| 82330 |
|
4,705 |
4,029 |
$91.63 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
6,517 |
5,308 |
$88.84 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
14,906 |
13,041 |
$88.26 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,993 |
4,047 |
$86.93 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
785 |
469 |
$80.52 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,456 |
2,265 |
$78.64 |
| J3480 |
Injection, potassium chloride, per 2 meq |
6,471 |
4,342 |
$74.01 |
| 82010 |
|
2,253 |
2,066 |
$71.31 |
| 82570 |
|
282 |
259 |
$69.70 |
| 29515 |
|
558 |
527 |
$69.38 |
| C9113 |
Injection, pantoprazole sodium, per vial |
6,009 |
3,587 |
$66.72 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
240 |
227 |
$65.76 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22,316 |
20,361 |
$65.04 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
1,682 |
1,104 |
$64.90 |
| G0008 |
Administration of influenza virus vaccine |
936 |
846 |
$63.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,442 |
2,261 |
$61.77 |
| 86769 |
|
905 |
876 |
$54.80 |
| 83615 |
|
946 |
780 |
$53.75 |
| 94770 |
|
287 |
263 |
$53.22 |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,379 |
1,074 |
$52.83 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
920 |
900 |
$52.27 |
| 80076 |
|
72 |
63 |
$52.16 |
| 85652 |
|
5,570 |
4,909 |
$52.08 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
141 |
137 |
$51.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,812 |
4,367 |
$50.80 |
| 76376 |
|
1,536 |
1,455 |
$50.22 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
4,010 |
3,180 |
$47.96 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,305 |
3,080 |
$46.93 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,561 |
3,093 |
$45.68 |
| 82731 |
|
288 |
261 |
$44.95 |
| 73620 |
|
636 |
558 |
$44.79 |
| 85046 |
|
3,202 |
2,736 |
$43.02 |
| 87045 |
|
1,397 |
1,322 |
$42.88 |
| C9399 |
Unclassified drugs or biologicals |
1,245 |
1,142 |
$41.01 |
| J7999 |
Compounded drug, not otherwise classified |
2,441 |
2,211 |
$40.61 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,984 |
2,366 |
$40.27 |
| 87340 |
|
378 |
351 |
$39.98 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
719 |
658 |
$35.90 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,584 |
1,610 |
$32.79 |
| 83540 |
|
2,336 |
2,172 |
$32.53 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,516 |
2,287 |
$30.16 |
| 82746 |
|
558 |
513 |
$28.24 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
493 |
463 |
$27.22 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
283 |
274 |
$25.30 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
609 |
584 |
$24.40 |
| 94664 |
|
915 |
770 |
$23.92 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
9,181 |
8,471 |
$22.41 |
| 73070 |
|
658 |
542 |
$21.46 |
| 87427 |
|
1,358 |
695 |
$19.08 |
| 87147 |
|
1,373 |
1,248 |
$18.82 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
820 |
645 |
$18.68 |
| J0456 |
Injection, azithromycin, 500 mg |
1,685 |
1,270 |
$18.50 |
| 85014 |
|
6,502 |
5,529 |
$17.93 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,527 |
1,451 |
$16.68 |
| 87205 |
|
4,530 |
3,601 |
$14.91 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,317 |
5,074 |
$14.88 |
| 82553 |
|
1,404 |
1,153 |
$13.89 |
| 84295 |
|
3,112 |
2,749 |
$13.45 |
| J1815 |
Injection, insulin, per 5 units |
14,240 |
6,541 |
$13.12 |
| 82435 |
|
1,499 |
1,384 |
$12.37 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
769 |
707 |
$12.25 |
| 86308 |
|
392 |
372 |
$10.71 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
330 |
225 |
$10.16 |
| 87449 |
|
1,673 |
1,394 |
$9.72 |
| 87807 |
|
909 |
881 |
$8.57 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
33 |
24 |
$7.38 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
327 |
284 |
$6.96 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
5,700 |
4,919 |
$4.60 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,733 |
1,475 |
$4.59 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
471 |
305 |
$3.87 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,012 |
758 |
$0.07 |
| Q0114 |
Fern test |
153 |
145 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
3,171 |
2,886 |
$0.00 |
| C1729 |
Catheter, drainage |
247 |
175 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
230 |
228 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
842 |
592 |
$0.00 |
| 87102 |
|
795 |
589 |
$0.00 |
| 85460 |
|
584 |
564 |
$0.00 |
| 99152 |
|
883 |
817 |
$0.00 |
| 89051 |
|
1,659 |
1,213 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
771 |
733 |
$0.00 |
| 64643 |
|
64 |
57 |
$0.00 |
| 73100 |
|
161 |
147 |
$0.00 |
| C1758 |
Catheter, ureteral |
485 |
434 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
83 |
73 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
173 |
148 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
182 |
151 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
1,408 |
1,203 |
$0.00 |
| 82248 |
|
492 |
420 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
204 |
190 |
$0.00 |
| 88302 |
|
121 |
105 |
$0.00 |
| 85007 |
|
262 |
223 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
407 |
395 |
$0.00 |
| 80202 |
|
47 |
39 |
$0.00 |
| 93325 |
|
328 |
287 |
$0.00 |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
57 |
56 |
$0.00 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
395 |
317 |
$0.00 |
| 83020 |
|
67 |
66 |
$0.00 |
| 86703 |
|
12 |
12 |
$0.00 |
| 85041 |
|
208 |
188 |
$0.00 |
| 87899 |
|
985 |
482 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
441 |
324 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
42 |
41 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
14 |
13 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
238 |
153 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
13 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
242 |
214 |
$0.00 |
| 87324 |
|
139 |
118 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
227 |
217 |
$0.00 |
| 88112 |
|
34 |
25 |
$0.00 |
| 29105 |
|
30 |
27 |
$0.00 |
| 76937 |
|
72 |
68 |
$0.00 |
| 85347 |
|
151 |
101 |
$0.00 |
| 51702 |
|
47 |
40 |
$0.00 |
| 82247 |
|
34 |
26 |
$0.00 |
| 93041 |
|
167 |
151 |
$0.00 |
| 94645 |
|
121 |
118 |
$0.00 |
| 88173 |
|
74 |
62 |
$0.00 |
| 25605 |
|
13 |
13 |
$0.00 |
| J9260 |
Injection, methotrexate sodium, 50 mg |
55 |
36 |
$0.00 |
| 82365 |
|
42 |
39 |
$0.00 |
| 83630 |
|
15 |
12 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
13 |
13 |
$0.00 |
| J2359 |
Injection, olanzapine, 0.5 mg |
52 |
38 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
85 |
44 |
$0.00 |
| 86922 |
|
22 |
15 |
$0.00 |
| 16020 |
|
27 |
24 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
12 |
12 |
$0.00 |
| 0115U |
|
21 |
21 |
$0.00 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
19 |
15 |
$0.00 |
| 87206 |
|
1,004 |
576 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
284 |
154 |
$0.00 |
| 87116 |
|
685 |
500 |
$0.00 |
| 90674 |
|
58 |
55 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
816 |
763 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
561 |
385 |
$0.00 |
| 82270 |
|
88 |
86 |
$0.00 |
| 87184 |
|
67 |
59 |
$0.00 |
| 74450 |
|
139 |
116 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
221 |
180 |
$0.00 |
| 90686 |
|
907 |
821 |
$0.00 |
| 74019 |
|
150 |
150 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
148 |
140 |
$0.00 |
| 87046 |
|
564 |
507 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
511 |
474 |
$0.00 |
| 82945 |
|
80 |
62 |
$0.00 |
| 93320 |
|
139 |
124 |
$0.00 |
| 85240 |
|
12 |
12 |
$0.00 |
| 96415 |
|
677 |
520 |
$0.00 |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
93 |
64 |
$0.00 |
| 80177 |
|
52 |
50 |
$0.00 |
| 87015 |
|
72 |
56 |
$0.00 |
| 12013 |
|
81 |
81 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
81 |
72 |
$0.00 |
| 97010 |
|
64 |
28 |
$0.00 |
| 87632 |
|
19 |
19 |
$0.00 |
| 86870 |
|
38 |
24 |
$0.00 |
| 77001 |
|
47 |
44 |
$0.00 |
| 73660 |
|
57 |
53 |
$0.00 |
| C1781 |
Mesh (implantable) |
81 |
75 |
$0.00 |
| 87176 |
|
16 |
12 |
$0.00 |
| 86762 |
|
25 |
25 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
87 |
81 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
41 |
29 |
$0.00 |
| 83090 |
|
16 |
16 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
27 |
25 |
$0.00 |
| 84157 |
|
97 |
78 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
84 |
71 |
$0.00 |
| 76377 |
|
25 |
25 |
$0.00 |
| 88311 |
|
47 |
42 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
30 |
30 |
$0.00 |
| 96411 |
|
18 |
14 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
18 |
13 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
95 |
78 |
$0.00 |
| 83921 |
|
14 |
14 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
15 |
15 |
$0.00 |
| 80178 |
|
41 |
36 |
$0.00 |
| 88331 |
|
14 |
12 |
$0.00 |
| 84300 |
|
14 |
14 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$0.00 |
| 86803 |
|
12 |
12 |
$0.00 |
| 90632 |
|
12 |
12 |
$0.00 |